Large-scale testing (Phase 3)Not Yet RecruitingNCT07160790
What this trial is testing
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Who this might be right for
Non-erosive Gastroesophageal Reflux Disease
Onconic Therapeutics Inc. 321